comparemela.com

Latest Breaking News On - Akston biosciences corporation - Page 1 : comparemela.com

Akston Biosciences Ends Vaccine Partnership with Stelis, Continues to Advance COVID Universal Booster EUA

Akston Biosciences Corporation, a developer of new classes of biologic therapeutics, announced today it has ended its AKS-452 licensing, manufacturing, and commercialization agreement with Stelis Biopharma Limited, an arm of Strides Pharma Science Ltd.

Todd zionAkston biosciencesJohnson janssenAkston biosciences corporationStrides pharma science ltdMerck coSmartcells incStelis biopharmaUnited statesEmergency use authorizationBiosciences corporationStelis biopharma limitedStrides pharma scienceMedia contactVaccine partnershipOvid universal booster

Akston Biosciences Doses First Participants in Phase II Clinical Trial for Shelf-Stable COVID-19 Booster

Akston Biosciences Doses First Participants in Phase II Clinical Trial for Shelf-Stable COVID-19 Booster

Linda pendergastTodd zionSchelto kruijffJohnson janssenAkston biosciencesAkston biosciences corporationBirnbach communications for akston biosciencesMerck coUniversity medical center groningenDechra pharmaceuticalsClinical research organizationSmartcells incRapid cure task forceEmergency use authorizationReceptor binding domainCure task force

Akston Biosciences Doses First Participants in Phase II Clinical Trial for Shelf-Stable COVID-19 Booster | Vaccines

Akston Biosciences Doses First Participants in Phase II Clinical Trial for Shelf-Stable COVID-19 Booster

United statesTodd zionSchelto kruijffJohnson janssenAkston biosciencesClinical research organizationUniversity medical center groningenI akston biosciences corporationRapid cure task forceAkston biosciences doses first participantsEmergency use authorizationUnited statesi mayAkston biosciences corporationReceptor binding domainCure task forceImmune therapy

Akston Biosciences Doses First Participants in Phase II Clinical Trial for Shelf-Stable COVID-19 Booster

Press release content from Business Wire. The AP news staff was not involved in its creation.

United statesLinda pendergastTodd zionSchelto kruijffJohnson janssenAkston biosciencesAkston bioscienceAkston biosciences corporationBirnbach communications for akston biosciencesMerck coUniversity medical center groningenDechra pharmaceuticalsClinical research organizationSmartcells incRapid cure task forceBiosciences corporation

Akston Biosciences Corporation: Akston Biosciences Doses First Participants in Phase II Clinical Trial for Shelf-Stable COVID-19 Booster

Up to 600 volunteers will participate in an AKS-452 COVID booster study in the Netherlands to investigate boosting the immune response of those previously vaccinated with EMA-registered vaccines

Linda pendergastTodd zionSchelto kruijffKostenloser wertpapierhandelJohnson janssenAkston biosciencesAkston bioscienceAkston biosciences corporationBirnbach communications for akston biosciencesMerck coUniversity medical center groningenDechra pharmaceuticalsClinical research organizationSmartcells incRapid cure task forceEmergency use authorization

vimarsana © 2020. All Rights Reserved.